Glasdegib Recruiting Phase 1 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02038777A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies